• Series Overview
• Program Content
• Faculty
• Target Audience
• Learning Objectives
• CPE Credit
• Recertification Credit
• Technical Requirements

The Literature Study Module provides immediate access to peer-selected, contemporary articles that are relevant to specialty practice. After learners read and analyze the articles and view the online presentation, they must successfully complete an online assessment to earn recertification credit.

Release date: October 23, 2019
ORIGINAL BCACP credit expiration date: April 21, 2020
EXTENDED BCACP credit expiration date: June 16, 2020
ACPE credit expiration date: October 22, 2022

The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 2 online home study activities (see table below). Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice.

Module 1A: Primary Prevention in Cardiovascular Disease and Pharmacy Practice: This module focuses on issues related to pharmacy practice including medication adherence and de-escalating inappropriate prescriptions, as well as primary prevention in cardiovascular disease.

Module 1B: Implementation Science: This module focuses on implementation science for pharmacists.

Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.

These activities are part of the ASHP and ACCP professional development program for BCACP recertification approved by the BPS.

Jennifer Bacci, Pharm.D., MPH, BCACP
Assistant Professor
Univesity of Washington
School of Pharmacy
Seattle, Washington

Amie Blaszczyk, Pharm.D., BCGP, BCPS, FASCP
Associate Professor and Division Head
Geriatrics and Pediatrics
Texas Tech University Health Sciences Center
Dallas, Texas

Joni Carroll, Pharm.D., BCACP
Pharmacist Senior Program Manager
Community Practice Development 
Community Leadership and Innovation in Practice Center
University of Pittsburgh School of Pharmacy
Pittsburgh, Pennsylvania

Stormi Gale, Pharm.D., BCPS, BCCP
Assistant Professor, Pharmacy Practice & Science
University of Maryland School of Pharmacy
Baltimore, Maryland

Nick Leon, Pharm.D., BCPS, BCACP, FCPP*
Associate Professor of Pharmacy Practice
Thomas Jefferson University
Jefferson College of Pharmacy
Philadelphia, Pennsylvania

Joel C. Marrs, Pharm.D., BCPS, BCACP, BCCP, CLS, ASH-CHC, FAHA, FASHP, FCCP, FNLA*
Associate Professor
University of Colorado Anschutz Medical Campus
Skaggs School of Pharmacy and Pharmaceutical Science
Aurora, Colorado
Clinical Pharmacy Specialist
Denver Health Medical Center
Denver, Colorado

* Content Matter Experts

These Literature Studies are designed to help board-certified pharmacists who are seeking recertification credit hours to maintain their Board of Pharmacy Specialties (BPS).

Module 1A: Primary Prevention in Cardiovascular Disease and Pharmacy Practice

• Explain the rationale, methodology, findings, limitations, and implications of the review of interventions to improve medication adherence.
• Describe common methods for detecting medication nonadherence and the characteristics of successful interventions to improve medication adherence.
• Plan strategies to detect and improve medication nonadherence.
• Explain the rationale, methodology, findings, limitations, and implications of the Developing Pharmacist-Led Research to Educate and Sensitize Community Residents to the Inappropriate Prescriptions Burden in the Elderly (D-PRESCRIBE) study.
• Devise a consumer-targeted pharmacist-led educational intervention to discontinue inappropriate medications in community-dwelling older adults.
• Explain the rationale, methodology, findings, limitations, and implications of A Study of Cardiovascular Events in Diabetes (ASCEND), which assessed the efficacy and safety of aspirin for primary prevention of cardiovascular events in patients with diabetes mellitus.
• Formulate recommendations for the use of aspirin for primary prevention of cardiovascular events in patients with diabetes mellitus without cardiovascular disease.
• Explain the rationale, methodology, findings, limitations, and implications of the systematic review and meta-analysis of aspirin use for primary prevention of cardiovascular events.
• Formulate recommendations for the use of aspirin for primary prevention in patients without cardiovascular disease, taking into consideration the risk for cardiovascular events and risk for bleeding.
• Explain the rationale, methodology, findings, limitations and implications of the Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial (REDUCE-IT).
• Formulate recommendations for the use of icosapent ethyl in patients with hypertriglyceridemia despite the use of statins.
• Describe the recommendations in the 2019 guideline from the American College of Cardiology (ACC) and American Heart Association (AHA) for primary prevention of cardiovascular disease.
• Formulate recommendations for the primary prevention of cardiovascular disease.

Module 1B: Implementation Science

• Define and discuss the principles of implementation science, including the terminology, history, frameworks, and methods and strategies for using these principles in research and real-world practice to accelerate change and maximize clinical, humanistic, and economic outcomes.
• Apply an evidence-based innovation (i.e., intervention, service, program, process, or guidelines) in a clinical practice setting using implementation science concepts and frameworks.
• Describe the stages of dissemination and implementation and the role of dissemination and implementation studies in the traditional translational pipeline for health research.
• Compare and contrast designs for dissemination and implementation strategies.
• Choose a study design and measures for use in dissemination and implementation research to improve health systems and outcomes.

The American Society of Health-System Pharmacists and American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by October 22, 2022.

Board certified pharmacists are eligible to receive up to 8 hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by June 16, 2020. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.